American Home Products Corporation v. Myra Sumlin

CourtMississippi Supreme Court
DecidedDecember 17, 2004
Docket2004-IA-02524-SCT
StatusPublished

This text of American Home Products Corporation v. Myra Sumlin (American Home Products Corporation v. Myra Sumlin) is published on Counsel Stack Legal Research, covering Mississippi Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Home Products Corporation v. Myra Sumlin, (Mich. 2004).

Opinion

IN THE SUPREME COURT OF MISSISSIPPI

NO. 2004-IA-02524-SCT

AMERICAN HOME PRODUCTS CORPORATION; WYETH-AYERST LABORATORIES COMPANY, A DIVISION OF AMERICAN HOME PRODUCTS CORPORATION; AND A. H. ROBINS COMPANY, INCORPORATED

v.

MYRA SUMLIN

DATE OF JUDGMENT: 12/17/2004 TRIAL JUDGE: HON. ROBERT G. EVANS COURT FROM WHICH APPEALED: SMITH COUNTY CIRCUIT COURT ATTORNEYS FOR APPELLANTS: WILLIAM M. GAGE KENNETH W. BARTON LEANN W. NEALEY ROBERT D. GHOLSON ATTORNEYS FOR APPELLEE: WILLIAM R. COUCH RICHARD JOSEPH LAJAUNIE THOMAS Q. BRAME, JR. NATURE OF THE CASE: CIVIL - OTHER DISPOSITION: REVERSED AND REMANDED -11/16/2006 MOTION FOR REHEARING FILED: MANDATE ISSUED:

BEFORE SMITH, C.J., DIAZ AND RANDOLPH, JJ.

SMITH, CHIEF JUSTICE, FOR THE COURT:

¶1. This case comes to this Court on appeal from the Circuit Court of Smith County,

Mississippi, by A.H. Robins Company, Incorporated, American Home Products Corporation,

and Wyeth-Ayerst Laboratories Company (“Wyeth”).1 In this pharmaceutical liability case,

1 According to Wyeth, on August 3, 1998, A.H. Robins Company, Incorporated, was merged into American Home Products Corporation, and ceased to exist as a separate entity. plaintiff Myra Sumlin asserts a claim of heart valve regurgitation purportedly caused by Redux,

a diet drug formerly marketed by Wyeth. Wyeth seeks review of the trial court’s analysis of

Sumlin’s eligibility to opt out of a Nationwide Class Action Settlement (“CAS”). Moreover,

Wyeth seeks review of the trial court’s order denying Wyeth’s motion to transfer venue.

¶2. We hold that the trial court erred in not transferring venue to the Circuit Court of

Wayne County, and we reverse and remand for transfer of venue to that court. We decline to

address Issues II and III.

FACTS AND PROCEDURAL HISTORY

¶3. Prior to 1997, approximately six million people ingested the diet drugs Pondimin

and/or Redux, which are also known as fen- phen. Brown v. Am. Home Prods. Corp., 2006 WL

572691, at *1 (E.D. Pa. March 8, 2006). The same year, these drugs were removed from the

market after evidence surfaced that the drugs could cause inter alia, valvular heart disease. Id.

The type of valvular heart disease at issue here is valvular regurgitation, which involves the

reverse flow of blood through defective heart valves. Id. After a wave of litigation following

the removal of the diet drugs from the market, the United States District Court of the Eastern

District of Pennsylvania approved a Class Action Settlement Agreement. Id.

¶4. Under the CAS, class members could initially opt out or remain in the class. Should

members choose to remain in the class, the CAS also provided “downstream” opt-out rights,

which would allow class members to sue Wyeth in state or federal court. These opt-out

On March 11, 2002, American Home Products Corporation changed its name to Wyeth. Additionally, on June 30, 2001, Wyeth-Ayerst Laboratories Company was merged into American Home Products Subsidiary Holding Corporation and ceased to exist as a separate entity.

2 provisions included an intermediate opt-out. However, in order to exercise intermediate opt-

out rights, class members had to be medically eligible under specific parameters as set forth

in the CAS.

¶5. The CAS, among other factors, requires class members who exercise intermediate opt-

out rights to have been diagnosed by a “qualified physician as FDA Positive by an

Echocardiogram.” Echocardiography is ultrasound technology used to produce an image

(echocardiogram) of the heart and the flow of blood through it. The CAS defines “FDA

Positive” by specifying both the qualitative and quantitative standards for evaluating the

echocardiogram used to diagnose regurgitation. Qualitatively, the CAS mandates the

echocardiogram must be performed and evaluated by qualified medical personnel following

the protocol as outlined by certain texts.2 Quantitatively, class members claiming mitral valve

regurgitation are eligible to opt-out only if diagnosed with moderate or greater mitral

regurgitation based on specified echocardiogram views. Specifically, “moderate or greater

regurgitation” is defined as “regurgitant jet area in any apical view equal to or greater than

twenty percent (20%) of the left atrial area.”

¶6. Sumlin filed suit against Wyeth in October of 2002, pursuing a claim against Wyeth as

an “Intermediate Opt-Out” from the CAS. Less than a month later, Wyeth filed a motion to

dismiss Sumlin’s complaint, arguing Sumlin failed to meet the opt-out requirements as

delineated by the CAS.

2 Harvey Feigenbaum, Echocardiography (5th ed. 1994) (“Feigenbaum”); Arthur E. Weyman, Principles and Practice of Echocardiography (2d ed. 1994) (“Weyman”).

3 ¶7. In December of 2004, the trial court held a hearing where both Sumlin and Wyeth

presented expert opinions as to whether Sumlin’s echocardiogram was performed in

compliance with the CAS requirements. The trial court also heard testimony as to whether

venue should be transferred from Smith County to Wayne County. The trial court denied

Wyeth’s motion to dismiss, Wyeth’s motion to transfer venue, as well as Wyeth’s motion for

reconsideration. In his order denying Wyeth’s motion to dismiss, the circuit judge based his

decision on Mississippi Rule of Civil Procedure 56 summary judgment standard and also found

the issue of whether Sumlin’s echocardiogram was “FDA Positive” was a fact issue for the

jury’s determination. Wyeth subsequently filed a petition for interlocutory appeal, which this

Court granted. See M.R.A.P. 5. Wyeth’s assertions of error are set forth below.

ISSUES

I. WHETHER THE TRIAL COURT ERRED IN DENYING A CHANGE OF VENUE IN LIGHT OF THE CLEAR PRECEDENT OF CAPITAL CITY INS. CO. v. G.B. “BOOTS’ SMITH CORP. AND ITS PROGENY.

II. WHETHER THE TRIAL COURT VIOLATED WYETH’S RIGHT UNDER THE CAS TO HAVE SUMLIN’S ELIGIBILITY DETERMINED BY THE COURT AS A THRESHOLD MATTER.

III. WHETHER THE TRIAL COURT IMPROPERLY DELEGATED TO THE JURY ITS GATEKEEPING FUNCTION UNDER DAUBERT AND MISS. R. EVID. 104 AND 702.

STANDARD OF REVIEW

¶8. With regard to Wyeth’s motion to transfer venue, the abuse of discretion standard

applies. Capital City Ins. Co. v. G.B. “Boots” Smith Corp., 889 So. 2d 505, 513 (Miss.

2004). “This Court will not disturb a trial judge’s ruling on appeal ‘unless it clearly appears

4 that there has been an abuse of discretion or that the discretion had not been justly and properly

exercised under circumstances of the case.” Id. (quoting Guice v. Miss. Life Ins. Co., 836 So.

2d 756, 758 (Miss. 2003)).

DISCUSSION

I. WHETHER THE TRIAL COURT ERRED IN DENYING A CHANGE OF VENUE IN LIGHT OF THE CLEAR PRECEDENT OF CAPITAL CITY INS. CO. v. G.B. “BOOTS’ SMITH CORP. AND ITS PROGENY.

¶9. Wyeth asserts the trial court erred when it denied its motion to transfer venue. First,

Wyeth asserts venue is improper in Smith County because the controlling venue statute is

Miss. Code Ann. Section 11-11-3,3 not Miss. Code Ann. Section 11-11-11. As such, section

11-11-11's clause which allows venue where a plaintiff resides or is domiciled, is

inapplicable.4 Secondly, Wyeth argues venue in Smith County is improper because under

section 11-11-3, Sumlin’s complaint names a Mississippi resident defendant,5 and Sumlin’s

claim did not occur or accrue in Smith County. “Of right, the plaintiff selects among the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Anderson
692 So. 2d 65 (Mississippi Supreme Court, 1997)
Senatobia Community Hosp. v. Orr
607 So. 2d 1224 (Mississippi Supreme Court, 1992)
Williamson v. Edmonds
880 So. 2d 310 (Mississippi Supreme Court, 2004)
Braswell v. T & T WELDING, INC.
883 So. 2d 82 (Mississippi Supreme Court, 2004)
Forrest County General Hosp. v. Conway
700 So. 2d 324 (Mississippi Supreme Court, 1997)
Thompson v. City of Vicksburg
813 So. 2d 717 (Mississippi Supreme Court, 2002)
Flight Line, Inc. v. Tanksley
608 So. 2d 1149 (Mississippi Supreme Court, 1992)
Capital City Ins. v. GB" Boots" Smith
889 So. 2d 505 (Mississippi Supreme Court, 2004)
Guice v. Mississippi Life Ins. Co.
836 So. 2d 756 (Mississippi Supreme Court, 2003)
Forman v. Mississippi Publishers Corp.
14 So. 2d 344 (Mississippi Supreme Court, 1943)

Cite This Page — Counsel Stack

Bluebook (online)
American Home Products Corporation v. Myra Sumlin, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-home-products-corporation-v-myra-sumlin-miss-2004.